Innovation Pharmaceuticals Inc. Quarterly Operating Lease, Payments in USD from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Innovation Pharmaceuticals Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q3 2019 to Q3 2023.
  • Innovation Pharmaceuticals Inc. Operating Lease, Payments for the quarter ending September 30, 2023 was $55K, a 6.78% decline year-over-year.
  • Innovation Pharmaceuticals Inc. annual Operating Lease, Payments for 2023 was $197K, a 20.1% increase from 2022.
  • Innovation Pharmaceuticals Inc. annual Operating Lease, Payments for 2022 was $164K, a 22.4% increase from 2021.
  • Innovation Pharmaceuticals Inc. annual Operating Lease, Payments for 2021 was $134K, a 42.5% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $55K -$4K -6.78% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q3 2022 $59K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q3 2021 $59K +$3K +5.36% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q3 2020 $56K -$2K -3.45% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-16
Q3 2019 $58K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.